INOVIO’s COVID-19 vaccine candidate provided broad cross-reactive immune responses In humans against variants
On Apr. 15, 2021, Inovio Pharmaceuticals announced the results of a study focusing on the human immune responses…
US, Chile and Peru interim trial data showed Oxford-AstraZeneca vaccine was safe and highly effective
On Mar. 22, 2021, Oxford University announced that a Phase III study of the Oxford-AstraZeneca coronavirus vaccine conducted…
Existing vaccines may protect against the Brazilian coronavirus variant
On Mar. 19, 2021, Scientists at the University of Oxford released pre-print data measuring the level of antibodies…
Roche launched SARS-CoV-2 variant test to help monitor emerging coronavirus mutations
On Mar. 16, 2021, Roche announced the launch of the cobasﾮ SARS-CoV-2 Variant Set 1 Test to detect…
Twist Bioscience began shipping of synthetic RNA controls for B.1.351 and P.1 variants
On Mar. 15, 2021, Twist Bioscience announced that it had started shipping its new synthetic RNA reference controls,…
T2 Biosystems T2SARS-CoV-2 panel proved capable of detecting the Brazil P1 variant of SARS-CoV-2 virus
On Feb. 4, 2021, T2 Biosystems announced that its T2SARS-CoV-2 Panel – a molecular diagnostic test that detects…
South Carolina detected first US cases associated with variant first detected in South Africa
On Jan. 28, 2021, the CDC announced that it had become aware of the first U.S. documented cases…
AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19
On Nov. 23, 2020, AstraZeneca announced positive high-level results from an interim analysis of clinical trials of AZD1222…
COVISHIELD completed enrollment of phase III clinical trials under partnership of ICMR and Serum Institute
On Nov. 11, 2020, the Serum Institute of India (SII) and Indian Council of Medical Research (ICMR) announced…
The CDC opened new South America Regional Office in Brazil
On Oct. 29, 2020, the Centers for Disease Control and Prevention (CDC) opened its new South America regional…
FDA authorised restart of the COVID-19 AZD1222 vaccine US phase III trial
On Oct. 23, 2020, AstraZeneca announced that the clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, had…
Global clinical trials of COVID-19 vaccine resumed
On Oct. 23, 2020, the U.S. FDA authorised a restart of clinical trials of the ChAdOx1 nCov-2019 Oxford…
Ionis antisense medicine evaluated in an investigator-initiated clinical study of COVID-19 patients in Brazil
On Oct. 15, 2020, Ionis Pharmaceuticals announced that IONIS-PKK-LRx was being evaluated in an investigator-initiated Phase 2 clinical…
Brazilian Health Regulatory Agency authorized Sorrento’s phase 2 clinical trial of Abivertinib in COVID-19 patients
On Oct. 14, 2020, Sorrento Therapeutics announced receipt of clearance from the Brazilian regulatory agency (ANVISA) to proceed…
COVID-19 vaccine AZD1222 clinical trial resumed in Japan, follows restart of trials in the UK, Brazil, South Africa and India
On Oct. 2, 2020, AstraZeneca announced the phase I/II clinical trial for the COVID-19 vaccine AZD1222 had resumed…
Brazil approved RedHill Biopharma’s phase 2/3 COVID-19 study with opaganib
On Sept. 22, 2020, RedHill Biopharma announced approval from the Brazilian Health Regulatory Agency (ANVISA) for its ongoing…
US Government stopped COVID-19 entry strategy for international air passengers
On Sept. 9, 2020, the U.S, government annunced that it will remove requirements for directing all flights carrying…
Sanofi updated Kevzara (sarilumab) phase 3 trial in severe and critically ill COVID-19 patients outside the US
On Sept. 1, 2020, Sanofi announced that the global Phase 3 trial investigating intravenously administered Kevzara (sarilumab) at…
Humanigen expands phase III study of lenzilumab in COVID-19 to Brazil
On Aug. 10, 2020, Humanigen announced that the Brazilian regulatory agency, Anvisa, had granted permission to commence a…
RedHill Biopharma accelerated phase 2/3 COVID-19 program with addition of Brazil and Mexico
On Jul. 22, 2020, RedHill Biopharma announced that it had submitted a Clinical Trial Application (CTA) with the…
Sinovac COVID-19 vaccine collaboration with Butantan received approval from Brazilian regulator for phase III trial
On Jul. 6, 2020, Sinovac Biotech announced that on Jul. 3, 2020, the Brazilian National Regulatory Agency, Anvisa,…
Albert Einstein College of Medicine invented compound tested in COVID-19 clinical trial
On Apr. 29, 2020, researchers at Montefiore Health System and Albert Einstein College of Medicine announced that a…
Chembio Diagnostics received $4 million purchase order from Bio-Manguinhos for production of DPP COVID-19 IgM/IgG system in Brazil
On Mar. 20, 2020, Chembio Diagnostics announced receipt of a $4 million order from Bio-Manguinhos for the purchase…
Chembio Diagnostics announced approval of Dengue point-of-care test by Brazilis Health Regulatory Agency
On May 7, 2019, Chembio Diagnostics announced the approval of its DPP Dengue System by Agência Nacional de…
Chembio Diagnostics received approval of Zika, Dengue and Chikungunya point-of-care multiplex test by Brazil’s Health Regulatory Agency
On Apr. 9, 2019, Chembio Diagnostics announced the approval of its DPP Zika/Dengue/Chikungunya System by Agencia Nacional de…
Zika virus circulation was confirmed in Brazil
On May 15, 2015, Zika virus circulation was confirmed in Brazil, and the Centers for Disease Control and…
Scientists decoded genome of Chagas disease
On Jun. 5, 2012, an international team of scientists decoded genome of Chagas disease. Previously, scientists had only…
DNA evidence used to identify Josef Mengele from skeletal remains
In 1992, DNA evidence was used to identify Josef Mengele from skeletal remains. Bone DNA analysis was therefore…
The CDC launched a smallpox campaign in Brazil to evaluate efficacy of jet ejector equipment in the field
In 1965, the U.S. Centers for Disease Control and Prevention (CDC) launched a smallpox campaign in Anapa, Brazil…
Johnson ﾠ&ﾠ Johnson expanded into Argentina and Brazil
In 1937, Johnson ﾠ&ﾠ Johnson expanded into Argentina and Brazil.